20 completed, 3 terminated, 2 withdrawn, 1 unknown. 9 Phase 2, 7 Phase 1, 4 Not applicable, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 7, Unknown 1, Withdrawn 1 |
| Phase 1 | 7 | Completed 7 |
| Not applicable | 4 | Completed 3, Withdrawn 1 |
| Phase 3 | 3 | Terminated 2, Completed 1 |
Follow Stage III Cervical Cancer: new trials by email Literature Review of Stage III Cervical Cancer trials Research Report on Stage III Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ask Questions (ASQ):Implementation of a Communication Intervention Behavioral Intervention - Stage II Breast Cancer, Stage III Breast Cancer | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 81 | 2021-08-25 | 2023-08-16 |
| Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer Nimotuzumab, Cisplatin, external-beam radiation - Neoplasms, Cervical Adenosquamous Cell Carcinoma | Phase 2 | Unknown | Zhujiang Hospital | 100 | 2018-03-20 | 2018-08-13 |
| Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners Cognitive Behavior Therapy, Quality-of-Life Assessment, Questionnaire Administration - Malignant Female Reproductive System Neoplasm, Malignant Hepatobiliary Neoplasm | Not applicable | Completed | Rutgers, The State University of New Jersey | 14 | 2017-12-06 | 2021-04-08 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors Informational Intervention - Stage I Breast Cancer, Stage I Cervical Cancer | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 40 | 2015-08-01 | 2025-04-29 |
| Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer Axalimogene filolisbac - Effects of Immunotherapy, Metastatic/Recurrent Cervical Cancer | Phase 1 | Completed | Advaxis, Inc. | 12 | 2015-03-04 | 2024-05-20 |
| MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer Computed Tomography, Diffusion Weighted Imaging, Dynamic Contrast-Enhanced Magnetic Resonance Imaging - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Terminated | University of Washington | 51 | 2014-02-14 | 2023-06-26 | |
| Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer External Beam Radiation Therapy, PDR Brachytherapy, Cisplatin - Cervical Adenocarcinoma, Stage IB Cervical Cancer | Phase 2 | Completed | Institut de Cancérologie de Lorraine | 48 | 2011-06-06 | 2026-09-01 |
| Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer Filgrastim, Laboratory Biomarker Analysis, Pegfilgrastim - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 27 | 2011-02-01 | 2019-08-08 |
| Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer Medical Chart Review, Questionnaire Administration - Recurrent Cervical Carcinoma, Recurrent Uterine Corpus Carcinoma | Completed | Gynecologic Oncology Group | 778 | 2010-07-01 | 2018-04-12 | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
| Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes proton beam radiation therapy, radiation therapy treatment planning/simulation, cisplatin - Cervical Cancer, Stage IB Cervical Cancer | Phase 2 | Withdrawn | Abramson Cancer Center at Penn Medicine | 2009-07-01 | 2020-04-03 | |
| Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer triapine, cisplatin, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Vaginal Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 26 | 2009-07-01 | 2017-11-17 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer Management of Therapy Complications, Quality-of-Life Assessment - Lymphedema, Stage 0 Cervical Cancer | Phase 3 | Terminated | Gynecologic Oncology Group | 2 | 2007-12-01 | 2021-06-23 |
| FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer 18F-fluoromisonidazole, fluorodeoxyglucose F 18, positron emission tomography - Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 16 | 2007-11-01 | 2016-12-30 |
| Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer fludeoxyglucose F 18, positron emission tomography, computed tomography - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 384 | 2007-09-01 | 2019-07-23 |
| Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer Topotecan Hydrochloride Liposomes, 3-Dimensional Conformal Radiation Therapy, Cisplatin - Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma | Phase 1 | Completed | Gynecologic Oncology Group | 11 | 2007-09-01 | 2014-12-31 |
| Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes Laboratory Biomarker Analysis, Lymphadenectomy - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Completed | Gynecologic Oncology Group | 159 | 2007-04-02 | 2017-08-24 | |
| Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer cisplatin, tirapazamine - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma | Phase 3 | Terminated | National Cancer Institute (NCI) | 402 | 2006-02-01 | 2019-07-23 |
| EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer EF5 - Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 60 | 2005-02-01 | 2013-01-16 |
Showing 20 of 26. Sign in to see all of them.
Uterine Cervical Neoplasms (26) · Breast Neoplasms (5) · Endometrial Neoplasms (5) · Vaginal Neoplasms (5) · Vulvar Neoplasms (5) · Carcinoma, Ovarian Epithelial (4) · Prostatic Neoplasms (4) · Fallopian Tube Neoplasms (3) · Ovarian Neoplasms (3) · Uterine Cervical Dysplasia (3) · Breast Neoplasms, Male (2) · Carcinoma, Islet Cell (2) · Carcinoma, Medullary (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2)
Female Urogenital Diseases (26) · Female Urogenital Diseases and Pregnancy Complications (26) · Genital Diseases (26) · Urogenital Diseases (26) · Genital Diseases, Female (25) · Genital Neoplasms, Female (25) · Neoplasms by Site (25) · Urogenital Neoplasms (25) · Uterine Cervical Diseases (25) · Uterine Diseases (25) · Uterine Neoplasms (25) · Neoplasms (24) · Adnexal Diseases (7) · Endocrine Gland Neoplasms (7) · Endocrine System Diseases (7)
Cisplatin (9) · Brachytherapy (4) · Fluorodeoxyglucose F18 (4) · Magnetic Resonance Spectroscopy (4) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (3) · Radiotherapy, Conformal (2) · 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · Behavior Therapy (1) · Cetuximab (1) · Cognitive Behavioral Therapy (1) · Colposcopy (1) · Epoetin Alfa (1) · Erythropoietin (1) · Filgrastim (1) · Gemcitabine (1)
Gynecologic Oncology Group (8) · National Cancer Institute (NCI) (7) · Abramson Cancer Center at Penn Medicine (1) · Advaxis, Inc. (1) · Barbara Ann Karmanos Cancer Institute (1) · Case Comprehensive Cancer Center (1) · Institut de Cancérologie de Lorraine (1) · Northwestern University (1) · Rutgers, The State University of New Jersey (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of Southern California (1) · University of Washington (1) · Zhujiang Hospital (1)
United States (22) · Canada (3) · China (1) · France (1) · Hong Kong (1) · Japan (1) · South Korea (1)
Charles Kunos (2) · Peter Rose (2) · Agustin Garcia (1) · Amy Halverson (1) · Andrea Barsevick, PhD (1) · Christina Chu (1) · Gillian Thomas (1) · Joseph Rajendran (1) · Kathleen Moore (1) · Levi Downs (1) · Lillie Lin (1) · Michael Cibull (1) · Michael Gold (1) · Mostafa Atri (1)
PMID 22105720, PMID 24395863, PMID 25937529, PMID 36185311
U10CA027469 (8), U10CA180868 (4), U10CA101165 (2), N01CM37008 (1), P30CA043703 (1), P30CA072720 (1), R01CA155454 (1), R21CA099346 (1), U01CA062502 (1), U01CA076576 (1)